Registration for a live webinar on 'Innovative Vaccines and Viral Pathogenesis: Insights from Recent Monkeypox (Mpox) Research' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Autoimmunity
- Etiology of autoimmune disease
- Induction of autoimmunity: mechanisms
- The spectrum of autoimmune diseases
- Organ-specific and non-organ-specific disorders
- Overlap of autoantibodies
- Stimulating anti-thyroid antibodies
- Placental transfer of stimulating anti-thyroid Abs
- The spectrum of autoimmune diseases (selection)
- Pathogenetic immune responses
- Role of auto-Abs in autoimmune diseases
- Anti-GBM, Goodpasture's syndrome (1)
- Anti-GBM, Goodpasture's syndrome (2)
- Anti-GBM disease membranes
- Type 2 reaction
- Anti-GBM, Goodpasture's syndrome (3)
- Type 3 reaction: formation of immune complexes
- SLE-ACR criteria
- Example of rash
- Class IV-S (A)
- Rise in anti-dsDNA and relapse
- Auto-Abs in lupus nephritis
- GBM-nucleosome-antibody interaction
- Auto-Abs to C1q: clinical associations
- Auto-Abs to C1q: relation to disease activity (1)
- Auto-Abs to C1q: relation to disease activity (2)
- Pathogenicity of anti-C1q in lupus nephritis (1)
- Pathogenicity of anti-C1q in lupus nephritis (2)
- ANCA-associated vasculitides
- Anti-neutrophil cytoplasmic Abs (ANCA)
- c-ANCA, anti-Pr3 and anti-MPO
- Pathogenetic pathways in the primary vasculitides
- ANCA-associated vasculitis: pauci-immune
- Clinical evidence for pathogenicity of ANCA (1)
- Clinical evidence for pathogenicity of ANCA (2)
- ANCA-induced PMN activation
- MPO-ANCA are pathogenic in vivo (1)
- MPO-ANCA are pathogenic in vivo (2)
- Are PR3-ANCA pathogenic in vivo?
- Nasal carriage of S. aureus and relapses of WG
- Are ANCA pathogenic?
- Pathogenic mechanisms of auto-Abs?
Topics Covered
- Loss of tolerance for "self"
- Immune response to "self"
- Self destruction
- Etiology of autoimmune diseases: endogenous and exogenous factors
- Mechanisms of autoimmunity
- The spectrum of autoimmune diseases
- Organ-specific and non-organ-specific disorders
- Overlap of autoantibodies
- Anti-thyroid antibodies
- Pathogenic immune responses
- Systemic autoimmune diseases
- Anti-GMB and Goodpasture's syndrome
- Anti-C1q
- ANCA-associated vasculitis
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Kallenberg, C. (2007, October 1). Pathogenic mechanisms of autoantibodies [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved November 21, 2024, from https://doi.org/10.69645/QVJS5465.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Cees Kallenberg has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.